- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.99 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x F99: 1-(5-chloranyl-4-methyl-benzimidazol-1-yl)-3-[(2R,3S)-3-oxidanylpiperidin-2-yl]propan-2-one(Non-covalent)
- 2 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)
ATP.2: 18 residues within 4Å:- Chain A: R.152, E.154, F.161, L.162, R.163, T.164, F.167, W.169, Q.237, G.238, G.239, T.240, G.274, T.276, R.278
- Ligands: F99.1, MG.4, MG.5
20 PLIP interactions:20 interactions with chain A- Hydrogen bonds: A:R.152, A:E.154, A:T.164, A:Q.237, A:Q.237, A:T.240, A:T.240, A:T.276, A:R.278
- Water bridges: A:R.163, A:R.163, A:R.163, A:Y.197
- Salt bridges: A:R.152, A:R.152, A:R.163, A:R.278
- pi-Stacking: A:F.167, A:F.167
- pi-Cation interactions: A:R.278
ATP.7: 18 residues within 4Å:- Chain B: R.152, E.154, F.161, L.162, R.163, T.164, F.167, W.169, Q.237, G.238, G.239, T.240, G.274, T.276, R.278
- Ligands: F99.6, MG.9, MG.10
19 PLIP interactions:19 interactions with chain B- Hydrogen bonds: B:R.152, B:E.154, B:E.154, B:R.163, B:T.164, B:Q.237, B:Q.237, B:T.240, B:T.240, B:T.276, B:R.278, B:R.278
- Water bridges: B:H.242
- Salt bridges: B:R.152, B:R.152, B:R.163, B:R.278
- pi-Stacking: B:F.167
- pi-Cation interactions: B:R.278
- 2 x ZN: ZINC ION(Non-covalent)
ZN.3: 4 residues within 4Å:- Chain A: C.448, C.453, C.495, C.497
5 PLIP interactions:4 interactions with chain A, 1 Ligand-Water interactions- Metal complexes: A:C.448, A:C.453, A:C.495, A:C.497, H2O.2
ZN.8: 4 residues within 4Å:- Chain B: C.448, C.453, C.495, V.496
3 PLIP interactions:3 interactions with chain B- Metal complexes: B:C.448, B:C.453, B:C.495
- 4 x MG: MAGNESIUM ION(Non-covalent)(Non-functional Binders)
MG.4: 2 residues within 4Å:- Chain A: R.163
- Ligands: ATP.2
No protein-ligand interaction detected (PLIP)MG.5: 2 residues within 4Å:- Chain A: Q.237
- Ligands: ATP.2
No protein-ligand interaction detected (PLIP)MG.9: 1 residues within 4Å:- Ligands: ATP.7
No protein-ligand interaction detected (PLIP)MG.10: 3 residues within 4Å:- Chain B: E.214, Q.237
- Ligands: ATP.7
No protein-ligand interaction detected (PLIP)- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Yoon, I. et al., Control of fibrosis with enhanced safety via asymmetric inhibition of prolyl-tRNA synthetase 1. Embo Mol Med (2023)
- Release Date
- 2023-07-05
- Peptides
- Bifunctional glutamate/proline--tRNA ligase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.99 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x F99: 1-(5-chloranyl-4-methyl-benzimidazol-1-yl)-3-[(2R,3S)-3-oxidanylpiperidin-2-yl]propan-2-one(Non-covalent)
- 2 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)
- 2 x ZN: ZINC ION(Non-covalent)
- 4 x MG: MAGNESIUM ION(Non-covalent)(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Yoon, I. et al., Control of fibrosis with enhanced safety via asymmetric inhibition of prolyl-tRNA synthetase 1. Embo Mol Med (2023)
- Release Date
- 2023-07-05
- Peptides
- Bifunctional glutamate/proline--tRNA ligase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B